Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2100048	Nonacog beta pegol	nonacog beta pegol	Injection	Biological Products(3.1)	Import Drug Application	2021-04-01	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-03-31	view
JXSL2100049	Nonacog beta pegol	nonacog beta pegol	Injection	Biological Products(3.1)	Import Drug Application	2021-04-01	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-03-31	view
JXSL2100050	Nonacog beta pegol	nonacog beta pegol	Injection	Biological Products(3.1)	Import Drug Application	2021-04-01	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-03-31	view
JXSL2100031	Mim8	denecimig	Injection	Biological Products(1)	Import Drug Application	2021-02-26	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-02-25	view
JXSL2100032	Mim8	denecimig	Injection	Biological Products(1)	Import Drug Application	2021-02-26	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-02-25	view
JXSL2100033	Mim8	denecimig	Injection	Biological Products(1)	Import Drug Application	2021-02-25	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-02-24	view
JXSL2100034	Mim8	denecimig	Injection	Biological Products(1)	Import Drug Application	2021-02-25	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-02-24	view
JXSL2100028	Semaglutide片	semaglutide	Tablet	Biological Products(2.2)	Import Drug Application	2021-02-19	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-02-18	view
JXSL2100027	Semaglutide片	semaglutide	Tablet	Biological Products(2.2)	Import Drug Application	2021-02-19	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-02-18	view
JXSL2100026	Semaglutide片	semaglutide	Tablet	Biological Products(2.2)	Import Drug Application	2021-02-19	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-02-18	view
JYSZ2100003	重组人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2021-01-28	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2021-01-27	view
JYSB2000682	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2020-12-30	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2020-12-30	view
JYSB2000681	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2020-12-30	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2020-12-30	view
JYSB2000668	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-22	view
JYSB2000663	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products(3.1)	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2021-01-11	view
JYSB2000670	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-15	view
JYSB2000667	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-22	view
JYSB2000673	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-15	view
JYSB2000666	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products(3.1)	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2021-01-11	view
JYSB2000672	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-15	view